CIBC Private Wealth Group
KRYS icon

CIBC Private Wealth Group’s Krystal Biotech KRYS Stock Holding History

CIBC Private Wealth Group’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.22K Buy
+9
New +$1.89K ﹤0.01% 2782
2024
Q3 		– Sell
-4
Closed -$765 – 3210
2024
Q2 		$765 Buy
+4
New +$672 ﹤0.01% 2933

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CIBC Private Wealth Group's KRYS Position: Q4 2025 in Review

CIBC Private Wealth Group opened a new position in Krystal Biotech (KRYS) in Q4 2025: 9 shares worth $2.22K. The stake represents ﹤0.01% of the portfolio and ranks #2782 among its holdings. This is a return to the name: CIBC Private Wealth Group previously reported a position in KRYS as recently as Q2 2024.

CIBC Private Wealth Group first reported a position in KRYS in Q2 2024 and has held it in 2 quarters since. 334 funds tracked by Wall St. Rank hold KRYS as of Q4 2025.

  • CIBC Private Wealth Group held 9 shares of Krystal Biotech worth $2.22K as of Q4 2025.
  • Krystal Biotech was a new CIBC Private Wealth Group position in Q4 2025.
  • Krystal Biotech made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2782 holding.
  • CIBC Private Wealth Group first reported a position in Krystal Biotech in Q2 2024 and has held it in 2 quarters since.
  • 334 funds tracked by Wall St. Rank held Krystal Biotech as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.